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ABSTRACT 
In Ayurvedic classics, the diseases caused by Vatha are considered as very serious diseases (Mahagada). One 
of the two pathological processes for the vitiation of Vatha is Avarana. Avarana is the disturbed movement of 
Vatha due to obstruction by other factors in the body. In the present social scenario, majority of diseases of 
Vatha are the result of Avarana, but the pathogenesis related to Avarana is least explored. Metabolic 
syndrome is one such lifestyle disease comprised of obesity, hyperglycemia, hypertension, hyper 
triglyceridemia and low HDL level. Majority of the symptoms of different Avarana conditions can be identified 
in patients presenting with metabolic syndrome. The general treatment protocol for Avarana is pacification of 
Vatha along with cleansing of channels and treatment of encroaching Dosha. Since metabolic syndrome is a 
disease with Avarana as the main pathophysiology, the treatment proposed by Acharyas for Avarana will be 
useful in metabolic syndrome. Since the vitiation is predominantly of Kapha and Meda, the drugs pacifying 
Kapha and Meda, cleansing of the channels, strengthening the tissues and not vitiating Vatha will be 
beneficial. The drugs may also be disease specific, like Pramehahara and Medodoshahara. Tinospora cordifolia 
(Guduchi) and Commiphora mukul (Guggulu) may be effective in metabolic syndrome since they are satisfying 
the above properties. Serious disease will develop, if the Avarana pathology is left untreated as evident in 
coronary artery disease.  
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INTRODUCTION
The objective of Ayurveda - health and longevity - 
can be achieved by maintaining the unimpaired movement 
of the biological dynamic force, Vatha[1]. According to 
Ayurveda, the diseases are the result of the vitiation of the 
Doshas[2], of that, the diseases caused by Vatha are 
considered as very serious (Mahagada)[3]. The 
pathogenesis of vitiation of Vatha is broadly classified into 
two, Dhathukshaya and Avarana[4]. The Dhathukshaya is 
the diminution of tissue elements (Dhathus) and Avarana 
is the disturbance in the movement of Vatha dosha by 
other factors in the body. Due to the excessive use of 
factors vitiating the anabolic factor (Kapha), the 
transformation factor (Pitha), tissue elements (Dhathu), 
waste products (Mala) etc, they will get vitiated, 
obstructing the normal movement of Vatha, resulting in 
Avarana. In the present social scenario, owing to 
prosperity and sedentary lifestyle, the chances of vitiation 
of Kapha, Pitha, Dhathu (tissue elements), Mala (waste 
products) etc are more and majority of diseases of Vatha 
are the result of Avarana rather than diminution of tissue 
elements. Metabolic Syndrome is a life style disorder 
attaining epidemic status all over the world. Obesity, 
Hyperglycemia, Hypertension, Hypertriglyceridemia and 
low HDL levels are the cardinal symptoms of Metabolic 
Syndrome. The mortality and morbidity are high due to 
Metabolic Syndrome, all around the world and there are 
lacunae in the prevention and treatment of this disease 
with Allopathic medicine. Ayurvedic diagnosis and 
treatment protocol can be used for a better management of 
this condition by exploring Avarana, since Avarana can be 
identified as the pathophysiology of this condition.  
Avarana- Pathophysiology 
Chakrapanidatta explains that in Avarana, the 
vitiation of Vatha is the result of the obstruction to 
spontaneous stimulation for movement[5]. Avarana can 
also be considered as Sanga, as an obstruction, Samsarga, 
the combination of two Doshas, and Vimargagamana the 
process of altering the direction of flow. The factor, which 
obstructs the pathway of Vatha, is called as ‘Avaraka’ and 
the Dosha (Vatha in general or its components) that is 
entrapped by Avaraka is called as Avritha. While naming 
Avarana, the name of the Avaraka is used as prefix and the 
name of Avritha is used as suffix. For E.g. in Kapha avritha 
Vatha, Kapha is the encroaching factor and Vatha is the 
entrapped Dosha. On analyzing Avarana, we can observe 
that the encroaching (Avaraka) factor will be aggravating 
first. Since Avarana is possible by Pitha, Kapha, the tissue 
elements (Dhathus), food (Anna), waste products (Mala), 
and subdivisions of Vatha[6], the etiological factors will be 
vitiating these factors initiating the pathogenesis 
(Shadkriyakala). Etiological factors explained for vitiation 
of Vatha (Swanidana), i.e. food with bitter (Thiktha), 
pungent (Kadu) or astringent (Kashaya) taste, ununctous 
quality (Rooksha) etc. will not be causing Avarana but 
Dhathukshaya. The different pathological processes for the 
development of Avarana are. 
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1. Avarana, the obstruction 
Owing to the excessive use of etiological factors, 
there will be vitiation of encroaching factors. The vitiated 
factors will obstruct the channels leading to impairment of 
the movement of Vatha. Once get obstructed, the Vatha 
may simply get lodged there, and may get covered by the 
obstructing factors. The functions of the encroaching 
factor will be exaggerated and that of entrapped will be 
reduced. For e.g. in Hemiplegia (Pakshaghatha) especially 
in the Kaphaja type, even though it is a disease of Vatha, 
we can observe the qualities of Kapha as coldness, edema 
and heaviness and a reduction in the functions of Vatha as 
loss of function and loss of sensation since it is in the 
entrapped state. [7] 
2. Avarana, the interaction  
Whenever there is an obstruction in the flow of 
Vatha, it may try to abolish the obstruction. If Vatha is not 
strong enough to nullify the encroaching factor, in the 
course of time, the encroaching factor and entrapped 
Vatha will get interacted. At this point of time the 
symptoms will be presented equally by both factors as in 
Vatharaktha. In extremities and joints (Sakha and Sandhi), 
Raktha and Vatha are obstructing the normal flow of each 
other. They will interact and Avarana will happen. [8] 
3. Avarana- the abnormal movement 
Because of the obstruction in the pathway of Vatha, 
the direction of flow will get altered and is known as 
Vimarga gamana. The abnormally moving Vatha will 
vitiate other Doshas, channels etc. In Swasa roga 
Samprapthi the symptoms produced are of abnormally 
moving (Thiryak gatha) Vatha due to obstruction by Kapha 
[9]. If Vatha is more powerful, it will shatter the obstructing 
factor and will carry the fragments along its altered 
pathway. This is happening in Grandhi visarpa. When 
Kapha or Raktha is obstructing Vatha, it will break Kapha 
or Raktha and will carry the fragment to skin, veins, 
tendons and muscle, making tumors. [10] 
While analyzing the symptomatology of various 
Avaranas, we can observe that some symptoms are of the 
aggravated factor and some are of the entrapped Vatha. 
Generally the symptoms of encroached factor will be 
predominant than entrapped Vatha. For e.g., in Kapha 
Avritha vatha the symptoms of Kapha are, coldness, 
heaviness, considerable relief by pungent food, inclination 
towards fasting, exercise, ununctous and hot ingredients 
and symptom of Vatha is colic pain only [11]. In some cases 
there will be the diminution of function of encroached 
Dosha, contrary to the general principle. For e. g., in Prana 
obstructed by Udana, the symptoms presented includes, 
loss of function of different parts of body, Ojus (vital 
essence), strength, and complexion and even death of the 
patient [12]. Here we can observe diminution of the function 
of encroached Dosha, Udana. The pathophysiology 
happening here is the provocation of the entrapped Prana 
due to obstruction by the encroached Udana. It can be 
concluded that the subtype of Vatha, whether it is in 
encroached or entrapped stage, the more powerful 
subdivision of Vatha will exhibit the aggravation of 
symptoms. Comparatively less powerful subtype will 
exhibit a diminution of symptoms. The majority of the 
etiological factors described in Ayurvedic classics for the 
vitiation of different channels are nourishing (Santha-
rpana) in character leading to obstruction (Sanga) type of 
Srothodushti. Entrapment of Vatha will take place during 
its movement through these channels.  
Diagnostic Considerations 
Mainly 42 types of Avarana are explained in the 
Ayurvedic classics[13]. The complexities of processes of 
Avarana make the diagnosis of Avarana very difficult. The 
factors involved in the pathology can be inferred from the 
symptoms and the site of manifestation. The learned 
physician, by keen observation of the symptoms and by 
utilization of the trial and error method of treatment, can 
diagnose the variety of Avarana precisely. [14] 
Treatment Principle 
The general treatment protocol for Avarana includes 
pacification of Vatha along with cleansing of channels and 
treatment of encroaching Dosha. Commiphora mukul 
(Guggulu) and black bitumen (Shilajith) along with milk 
are indicated because they are the best rejuvenating drugs 
and can normalize the channels and tissues by the cutting 
(Chedana) property. The different treatment modalities of 
Avarana are detailed in Ayurvedic classics.[15] 
Complications 
If the Avarana pathology is not treated properly, 
heart diseases (Hridroga), abscesses (Vidradhi), 
splenomegaly (Pleehavridhi), phantom tumor (Gulma), 
reduction of digestive fire (Agnisadana) etc will develop 
[16]. In Hridroga, the morbid Doshas will vitiate the rasa 
Dhathu and changes its quality. If Kapha is the vitiating 
rasa, coating (Lepana) of the channel happens resulting in 
obstruction type of vitiation of channels, entrapping the 
movement of Vatha, as evidenced in atherosclerosis of 
coronary arteries. If this pathology is persisting for more 
than one year, and if not treated properly, will lead to 
ischemic heart diseases and finally myocardial infarction.  
Metabolic Syndrome 
 Metabolic Syndrome is condition where 
hyperglycemia, hypertension, hypertriglyceridemia, 
reduced HDL (high density lipoprotein) and increased 
waist circumference coexist[17]. It arises from insulin 
resistance accompanying abnormal adipose tissue 
function. It is a risk factor for diabetes mellitus, coronary 
artery disease, fatty liver etc. Prevention and early 
intervention of Metabolic Syndrome are very much 
important in combating Type 2 diabetes and its 
complications.  
The new definition of Metabolic Syndrome by American 
Heart Association (AHA/NHLBI) [18, 19] is 
 Elevated waist circumference:  
o Men — greater than 40 inches (102 cm)  
o Women — greater than 35 inches (88 cm) 
 Elevated triglycerides: Equal to or greater than 
150 mg/dL (1. 7 mmol/L)  
 Reduced HDL ("good") cholesterol:  
o Men — Less than 40 mg/dL (1.03 mmol/L)  
o Women — Less than 50 mg/dL (1.29 mmol/L) 
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 Elevated blood pressure: Equal to or greater than 
130/85 mm Hg or use of medication for hypertension.  
 Elevated fasting glucose: Equal to or greater than 
100 mg/dL (5.6 mmol/L) or use of medication for 
hyperglycemia. 
Etiology 
 Insulin resistance 
 Insulin resistance is the main etiological factor of 
Metabolic Syndrome. It is a condition where cells fail to 
respond to insulin hormone.[20] Insulin is regulating the 
delivery of glucose to cells for energy production. In the 
condition of insulin resistance, glucose, amino acids and 
fatty acids will not enter into the cells and this result in the 
increase of blood glucose levels above normal range. [21] 
The liver regulates glucose levels by reducing the secretion 
of glucose but this is not happening in the patients with 
insulin resistance.  
 In fat cells insulin resistance results in reduced 
uptake of glucose and circulating lipids and increased 
hydrolysis of stored triglycerides leading to elevated free 
fatty acid levels in blood plasma. In liver cells it results in 
reduced glycogen synthesis, storage, failure to suppress 
glucose production and its release into blood. The 
increased mobilization of stored lipids in these cells 
elevates free fatty acids in blood. Elevated free fatty acids 
in blood, reduced muscle glucose uptake, increased liver 
glucose production and reduced glycogen synthesis 
contribute to elevated blood glucose levels. [22] At this 
stage, if more insulin is not secreted by pancreas, blood 
glucose concentration increases and type 2 diabetes 
mellitus occurs.  
 Increased waist circumference 
Increased waist circumference may be due to an 
increase in subcutaneous adipose tissue or visceral 
adipose tissue. Increase in visceral adipose tissue results in 
release of more adipose tissue derived free fatty acids and 
are directed to liver. But subcutaneous adipose tissue 
release lipolysis product into systemic circulation and 
avoid direct effect on hepatic metabolism. The greater 
prevalence of metabolic syndrome in Indians is due to 
relative increase in visceral adipose tissue than the 
subcutaneous adipose tissue.  
 Dyslipidemia 
 In insulin resistance, increased flux of free fatty 
acid to the liver increases triglyceride synthesis and thus 
hypertriglyceridemia is an excellent marker of insulin 
resistance. In presence of hypertriglyceridaemia, there is a 
decrease in the cholesterol content of HDL making the 
particle small and dense resulting in increased elimination 
of HDL from the circulation. Thus the reduction of HDL 
cholesterol in Metabolic Syndrome is a consequence of 
changes is HDL composition and metabolism.  
 Glucose intolerance 
 The defect in insulin action leads to reduced 
glucose uptake and metabolism by muscle and adipose 
tissue and impaired suppression of glucose production by 
liver and kidney. For maintaining euglycemia, insulin 
action and insulin clearance will be modified. Ultimately 
this compensatory mechanism fails resulting in diabetes 
mellitus.  
 Hypertension 
 Insulin is a vasodilator and is having effect on 
sodium absorption from kidney. In insulin resistance 
vasodilator effect will be lost decreasing the blood flow but 
the renal effect on sodium reabsorption will be maintained 
leading to increased blood pressure.  
 Proinflammatory cytokines 
 In metabolic syndrome the increased adipose 
tissue mass lead to an increase in production of pro-
inflammatory cytokines, including interlukin 1, 6 and 18 
(IL-1, IL-6, IL-18), resistin, tumor necrosis factor (TNF) α 
and C-reactive protein. Macrophages derived from adipose 
tissue are the primary source of pro-inflammatory 
cytokines.  
 Prothrombotic state 
It is characterized by increased plasma 
plasminogen activator inhibitor (PAI)-1 and fibrinogen. 
Fibrinogen, an acute-phase reactant like CRP, rises in 
response to a high-cytokine state. Thus prothrombotic and 
proinflammatory states also associate with the metabolic 
syndrome. [23] 
Clinical Features 
 The metabolic syndrome is not associated with 
defined symptomatology. General findings include 
increased waist circumference, elevated BP, lipoatrophy, 
Acanthosis Nigricans, inability to focus, depression, high 
blood sugar, increased hunger, intestinal bloating, 
sleepiness after meals, fat storage, weight gain and 
difficulty in losing weight.  
Pathophysiology 
 In metabolic syndrome, adverse clinical 
consequences occur through multiple mechanisms. But the 
major pathophysiology behind target organ damage is 
insulin resistance and micro vascular dysfunction. Other 
factors attributed to organ damage are increased 
thrombogenesity of circulating blood, endothelial 
dysfunction, increased arterial stiffness etc.  
Diagnosis 
 The diagnosis of metabolic syndrome is based on 
physical and laboratory features and may be suspected if 
the symptoms of any component disorder are present like 
increased urination, thirst and hunger in diabetes mellitus. 
Patient reporting a history of diabetes mellitus, 
hypertension or dyslipidaemia may be screened for 
metabolic syndrome. Since it is a lifestyle disease, dietary 
habits, exercise routines etc. are to be enquired. Additional 
risks such as tobacco use are to be considered for the 
screening of complications like cardiovascular disease. 
Family history may be obtained since genetics and 
environmental factors are playing a major role in the 
manifestation of the disease. A thorough systemic 
examination is essential for identifying associated diseases 
such as cardiovascular disease, Type 2 diabetes mellitus, 
Polycystic ovary disease, Non alcoholic fatty liver disease, 
Hyperuricemia, Obstructive sleep apnoea etc.  
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Laboratory Investigations 
 The laboratory investigations to assess metabolic 
syndrome includes lipid profile, fasting and post prandial 
blood sugars. Other helpful blood tests may include 
thyroid function tests, liver function tests, renal function 
tests and HbA1C. Studies of lipoprotein (a), apolipoprotein 
B 100, high sensitivity C-reactive protein, homocystine and 
fractionated LDL-C are to be considered in patients with a 
history of early coronary artery disease or other 
atherosclerotic disease. Further laboratory studies should 
be selected as clinical conditions demands. [24] 
Avarana in Metabolic Syndrome  
Metabolic syndrome is a major lifestyle disease 
prevalent all over the world, imparting burden on society 
in terms of health hazards, expenditure for the treatment 
and reduction in productivity. Since it is a chronic disease, 
long term treatment is essential and the complications 
caused by the disease as well as the treatment with 
allopathic medicines are increasing the mortality and 
morbidity of the patient. A better protocol incorporating 
Ayurveda is necessary for reducing the mortality and 
morbidity and improving the quality of life of the patients.  
The disease conditions described in Ayurveda, 
which can be correlated with Metabolic Syndrome, are 
Athistoulya (obesity), Madhumeha (Diabetes mellitus) 
Medodosha (dyslipidaemia) and Vathavyadhi (Hyper-
tension). Acharyas emphasized the role of Avarana in the 
pathogenesis (Samprapthi) in Athistoulya (obesity) and 
Madhumeha (Diabetes mellitus). Even though Hyper-
tension, one of the components of Metabolic Syndrome, is 
not explained in Ayurvedic classics, its symptoms can be 
observed in various Avarana conditions. Thus it can be 
concluded that Avarana is playing a major role in the 
manifestation of Metabolic Syndrome. Exploration of 
Avarana pathology in Metabolic Syndrome, in terms of 
etiology (Hethu), symptomatology (Linga) and 
management (Oushadha), will bring hopeful results in the 
management of Metabolic Syndrome. The analysis of the 
disease can be done by exploring the etiology (Nidana), 
prodromal symptoms (Poorvaroopa), signs and symptoms 
(Roopa), trial and error treatment (Upasaya) and 
pathogenesis (Samprapthi).  
1. Etiology (Nidana) 
In Metabolic syndrome, by scrutinizing the 
etiology of vitiation of various channels (Srothas), we can 
observe that the causes of vitiation (Dushti nidanas) 
described separately for different channels (Srothas) and 
tissues (Dhathu) are overlapping each other. Majority of 
the etiology (Nidanas) are over nourishment (Santha-
rpana) in character like excess food (Athyasana), heavy 
food (Guru anna), unctuous food (Snigdha anna) etc., 
thereby increasing Kapha and other gentle, soft and cool 
factors (Saumya bhavas) and resulting in obstruction 
(Sanga) type of Srothodushti and will be the primary cause 
of Avarana of Vatha. The etiology of vitiation of Vatha in 
metabolic syndrome will be just opposite to the etiological 
factors described for the vitiation of Vatha in classical texts 
like food with bitter taste etc., (Thikthoshanadi 
swanidanas). In the present social circumstances due to 
excess food intake and sedentary life style, the prevalence 
of diseases due to over nourishment (Santharpanajanya 
rogas) is more. In metabolic syndrome, as per modern 
pathology, insulin resistance is the leading cause which is 
nothing other than the result of increased free fatty acids 
in the blood due to the over nourishment. It is blocking the 
entry of glucose into the cell resulting in obstruction 
(Sanga) type of vitiation of Srothas. Thus the importance of 
Srothodushti in manifestation of metabolic syndrome can 
be well established.  
The causative factors for the manifestation of 
Athisthoulya and Prameha are detailed in the classics. This 
will be the recent cause (Sannikrishta nidana) of metabolic 
syndrome.  
They are Sweet food (Swadu anna), Sour food 
(Amlaanna), Salty food (Lavanaanna), Unctuous food 
(Snigdhaanna), Heavy food (Guruanna), Slimy food 
(Pischilaanna), Cold food (Seethalaanna), Fresh grains 
(Navadhanya), Beer (Sura), Meat of animals of marshy 
places (Anoopamamsa), Sugarcane juice (Ikshu), Molasses 
(Guda), Milk (Gorasa), Habit of sitting for long time 
(Ekastaana asana rathi), Sleeping without adopting proper 
procedure (Vidhivarjitha sayanam)[25,26]. The etiological 
factors of obesity (Athisthoulya) as described by Acharya 
Charaka are Overeating (Athisampooranam), Heavy food 
(Guruanna), Sweet food (Madhuraanna), Cold food 
(Seethaanna), Unctuous food (Snigdhaanna), Abstinence 
from sexual intercourse (Avyavaya), Lack of exercise 
(Avyayama), Sleeping in day time (Divaswapna), Persistent 
euphoria (Harshnithyatwa), Genetic causes (Beejaswa-
bhava) [27].  
In channels (Srothas) also, Medo vaha srothas 
should be given prime importance because the basic 
pathology is occurring in this Srothas. The remote causes 
(Viprakrishta nidanas) are setting the background for the 
manifestation of the diseases. The lack of exercise 
(Avyayama), sleeping during day time (Divaswapna), heavy 
food (Medyanam athibhakshanam) and alcoholism (Varuni 
sevana) are the etiological factor for the Medovaha srotho 
dushti[28]. It can be considered as the stage setter of 
metabolic syndrome.  
Insulin resistance can be included under the 
heading of the definite cause (Pradhanika hethu) because it 
is resulting in the disease definitely.  
2. Prodromal Symptoms (Poorvaroopa) 
Some of the prodromal symptoms of Prameha 
described in Ashtanga hridaya can be identified in early 
stages of metabolic syndrome like desire for the comfort of 
bed, seat and sleep (Sayyasugham, Asana sugham, Swapna 
sugham), coating of heart, eyes, tongue and ears 
(Hritnethrajihwa sravana upadeham), stoutness of body 
(Ghanangatha), excess growth of hairs and nails (Kesa 
nagha athivridhi), desire for cold (Seethapriyatwam) etc[29]. 
The symptoms of insulin resistance can be considered as 
the prodromal symptoms of metabolic syndrome. It 
includes brain fogginess and inability to focus, intestinal 
bloating, sleepiness especially after meals, weight gain, fat 
storage, difficulty losing weight, depression and increased 
hunger.  
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3. Symptomatology (Roopa) 
The cardinal symptom of Prameha, i.e., excess and 
turbid urine (Prabhootha avila moothratha) [30] and that of 
Athisthoulya i.e., pendulous buttocks, abdomen and breasts 
(Chala sphig udara sthana) and disproportionate strength 
with physical growth (Ayadhopachaya uthsaha) [31] can be 
identified in Metabolic syndrome. Since Avarana is the 
pathophysiology behind the manifestation of Metabolic 
syndrome, symptoms exhibited in various Avarana 
conditions can be identified in patients with Metabolic 
syndrome. 211 symptoms are described in various 
Avarana conditions and patients with Metabolic syndrome 
are exhibiting majority of these symptoms. In clinical 
practice, increased waist circumference, elevated blood 
pressure, lipoatrophy and Acanthosis nigricans may be 
found during physical examination alerting physician to 
search for biochemical abnormalities.  
4. Trial and Error Treatment (Upasaya)  
 Since types of Avarana are innumerable, Acharyas 
emphasizes the onset of symptoms and the application of 
trial and error method of treatment (Upasaya) for 
identifying the underlying factors[32]. In metabolic 
syndrome also, a treatment protocol based on Avarana 
pathology has to be formulated on the basis of 
symptomatology and the pathogenesis can be tested by the 
use of trial and error method of treatment (Upasaya).  
5. Pathophysiology (Samprapthi) 
Pathophysiological factors (Samprapthi Ghatakas) of 
Metabolic syndrome 
Samprapthi Ghataka chiefly constitutes Dosha, 
Dooshya, Srothas, Ama and Agni.  
1. Dosha : Kapha and Vatha are the main Dosha involved in 
metabolic syndrome. Kapha is responsible for 
Margavarana of Vatha leading to Vathakopa.  
2. Dooshya : In metabolic syndrome, the main Dooshya 
involved is Medodhathu and subsequently other Dhathu 
will get vitiated. The involvement of other factors like 
Rasa, Raktha, Mamsa, Majja, Sukra, Ojus, Vasa, Lasika, 
Udaka etc. are responsible for the different clinical 
presentation of metabolic syndrome.  
3. Srothas: In metabolic syndrome mainly involved 
Srothas is Medovaha srothas. The effect of Srothodushti will 
be reflected in other channels (Srothas) leading to different 
diseases as Type 2 diabetes mellitus, cardiovascular 
disease etc. Athipravrithi, Sanga, Sira grandhi and Vimarga 
gamana are the four types of Srothodushti. All these types 
of Srothodushti are observed in metabolic syndrome.  
4. Agni: All diseases occur due to vitiation of Agni. In 
metabolic syndrome, digestive fire in stomach (Jataragni) 
and digestive fire in tissues (Dhatwagni) are important. 
Because of obstruction of pathway of Vatha by Medas 
(Medasavrithamarga) Vatha will be directed to the major 
channel (Koshta), increase digestive fire (Jataragni) and 
the person will consume more and more food and will 
become more obese. This result in release of more free 
fatty acids, and increased FFAs vitiates the digestive fire in 
tissues (Dhatwagni). Due to Dhathwagni dushti the 
metabolism of Medas will be deranged leading to 
accumulation of free fatty acids (Snigdhamsa) in the 
circulation, which in due course leads to development of 
insulin resistance. This Avarana condition if not treated 
properly and lasts for more than one year leads to 
Agnisadana (may be correlated with the reduction in 
insulin production and its effectiveness on cells) which is 
one of the complication of Avarana and finally results in 
diabetes mellitus.  
5. Ama: The accumulation of free fatty acids in the 
circulation can be considered as Ama in the case of 
metabolic syndrome. It hampers Dhathwagni leading to 
further worsening of insulin resistance which is the key 
pathology in the metabolic syndrome.  
The process of Samprapthi 
Santharpanakara Ahara, Vihara And Manasika Bhava 
(Over nourishing food, activities and emotions) 
 
Sleshma, Medas Athivridhi            Athisthoulyam, Medodosham, 
 
Avarana of Vatha          Vathakopam, 
 
Vitiated Vatha drags Ojus and reaches Vasthi          Madhumeham 
 
Metabolic Syndrome 
Treatment 
Treatment (Chikitsa) is nothing other than the 
breakage of pathophysiology (Samprapthi). Since 
metabolic syndrome is a disease with Avarana as the main 
pathophysiology, the treatment proposed by Acharyas for 
Avarana will be useful in metabolic syndrome. Since the 
vitiation is predominantly of Kapha and Meda, the drugs 
pacifying Kapha and Meda, cleansing the channels, 
strengthening the tissues and pacifying Vatha will be 
beneficial(33). The drugs may also be disease specific, like 
Pramehahara and Medodoshahara.  
Tinospora cordifolia (Guduchi) and Commiphora 
mukul (Guggulu) may be effective in metabolic syndrome 
since they are satisfying the above properties. Tinospora 
cordifolia (Guduchi) is Tridoshasamaka, Samgrahi, Balya, 
Dipana, Rasayana, Raktasodhana and is useful in Kushta, 
Vatarakta, Jvara, Kamala, Pandu and Prameha. 
Commiphora mukul (Guggulu) is pacifying Vatha and 
Kapha (Vatavalasajith), It is useful in Amavatha, Grandhi, 
Sopha, Gandamala, Medoroga, Prameha, Kushta. [34] 
 These two drugs may be beneficial in metabolic 
syndrome since they are effective in relieving the Avarana 
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pathology. On analyzing the properties they are pacifying 
all the three Doshas, cleansing the Srothases, pacify the 
Medodosha and are disease specific like Pramehahara(35) 
and Medodoshahara(36). Moreover they are Balya and 
Rasayana in properties.  
CONCLUSION 
 Since metabolic syndrome is attaining epidemic 
status all over the world, it is high time to establish the 
measures to prevent manage and palliate the disease. 
Ayurveda is having the potential in controlling this lifestyle 
disease without resulting in other complications. The 
established treatment modalities for metabolic syndrome 
in Ayurveda are not sufficient to meet the threat of this 
epidemic disease. A reassessment of Metabolic Syndrome 
on the basis of Avarana will show a better method in the 
prevention of metabolic syndrome, management of the 
disorder and its complications. Thus Ayurveda can 
improve the health and increase longevity of patients with 
Metabolic Syndrome.  
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